Meridian Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
8,364
+132
+2% +$47.1K 0.39% 56
2025
Q4
$2.69M Sell
8,232
-67
-0.8% -$21.3K 0.37% 54
2025
Q3
$2.34M Buy
8,299
+85
+1% +$24.7K 0.33% 56
2025
Q2
$2.29M Buy
8,214
+49
+0.6% +$13.9K 0.36% 55
2025
Q1
$2.54M Buy
8,165
+1
+0% +$295 0.43% 50
2024
Q4
$2.13M Buy
8,164
+54
+0.7% +$16K 0.35% 55
2024
Q3
$2.61M Buy
8,110
+102
+1% +$33.4K 0.44% 52
2024
Q2
$2.5M Hold
8,008
0.45% 50
2024
Q1
$2.28M Sell
8,008
-190
-2% -$55.6K 0.43% 51
2023
Q4
$2.36M Hold
8,198
0.52% 49
2023
Q3
$2.2M Sell
8,198
-10
-0.1% -$2.5K 0.55% 47
2023
Q2
$1.82M Sell
8,208
-460
-5% -$107K 0.44% 54
2023
Q1
$2.1M Hold
8,668
0.52% 50
2022
Q4
$2.28M Sell
8,668
-11
-0.1% -$2.95K 0.59% 45
2022
Q3
$1.96M Sell
8,679
-39
-0.4% -$9.45K 0.55% 41
2022
Q2
$2.12M Sell
8,718
-250
-3% -$61.3K 0.56% 47
2022
Q1
$2.17M Buy
8,968
+340
+4% +$78.1K 0.5% 49
2021
Q4
$1.94M Sell
8,628
-50
-0.6% -$10.6K 0.47% 54
2021
Q3
$1.84M Sell
8,678
-390
-4% -$89.8K 0.51% 53
2021
Q2
$2.21M Sell
9,068
-1,692
-16% -$416K 0.63% 35
2021
Q1
$2.68M Hold
10,760
0.89% 24
2020
Q4
$2.47M Sell
10,760
-49
-0.5% -$11.3K 0.9% 21
2020
Q3
$2.75M Buy
10,809
+140
+1% +$34.7K 1.18% 17
2020
Q2
$2.52M Buy
10,669
+2,180
+26% +$497K 1.16% 19
2020
Q1
$1.72M Sell
8,489
-108
-1% -$23.6K 0.95% 22
2019
Q4
$2.07M Hold
8,597
0.82% 27
2019
Q3
$1.66M Buy
8,597
+58
+0.7% +$11.1K 0.71% 29
2019
Q2
$1.59M Sell
8,539
-60
-0.7% -$10.7K 1.11% 17
2019
Q1
$1.63M Hold
8,599
1.19% 14
2018
Q4
$1.67M Buy
+8,599
New +$1.68M 1.29% 13

Other funds holding AMGN

Meridian Wealth Advisors's AMGN Position: Q1 2026 in Review

Meridian Wealth Advisors increased its Amgen (AMGN) stake by 1.6% in Q1 2026, buying an estimated $47.1K and bringing the position to 8,364 shares worth $2.94M. The position accounts for 0.39% of the portfolio, ranked #56.

Meridian Wealth Advisors first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Meridian Wealth Advisors held 8,364 shares of Amgen worth $2.94M as of Q1 2026.
  • Meridian Wealth Advisors bought 132 Amgen shares in Q1 2026, an estimated $47.1K.
  • Amgen made up 0.39% of Meridian Wealth Advisors's portfolio in Q1 2026, its #56 holding.
  • Meridian Wealth Advisors first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Meridian Wealth Advisors's 13F filing for Q1 2026, filed 11 May 2026.